Cargando…
Botox (OnabotulinumtoxinA) for Treatment of Migraine Symptoms: A Systematic Review
BACKGROUND: Migraine is one of the most common types of headache, and it is the second most common cause of neurological disorders, with an annual prevalence of about 15% of the population. This study aimed to evaluate the effect of BoNT-A on the duration and intensity of migraine attacks. In additi...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Hindawi
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989603/ https://www.ncbi.nlm.nih.gov/pubmed/35401888 http://dx.doi.org/10.1155/2022/3284446 |